Awareness of Korean pharmaceuticals, ranked 7th out of 13

leading bio health countries

Recognition of top manufacturers in manufacturing exports

Overseas awareness of Korean health products continues to rise

In an awareness survey conducted on overseas consumers in countries leading the world's bio-health industry, they ranked 7th out of 13 countries in the pharmaceutical sector, 7th out of 15 countries in the medical device sector, 3rd out of 12 countries in the cosmetics sector, and 3rd out of 12 countries in the medical service sector.

 

It was ranked 5th out of 14 countries.

 

In the case of pharmaceutical respondents, 75.3% were aware of Samsung Biologics.

 

Daewoong Pharmaceutical 34.2%, Hanmi Pharmaceutical 33.8%, GC Pharma 31.7%, Celltrion 30.3%, SK Bioscience 29.9%, Yuhan Corporation 26%, Hugel 23.5%, Seegene 18.2%, Donga ST 15.1%.

 

All companies in each sector were selected as the top companies in terms of manufacturing exports in 2021, and it is a figure that confirms whether or not they are each company, rather than selecting companies known to them in terms of ranking.

 

On the 14th, the Korea Health Industry Development Institute (President Cha Soon-do) announced the '2022 Korean Bio-Health Industry (Manufacturing and Medical Service) Overseas Awareness Survey' with these contents.

 

The countries surveyed were 19 countries (25 cities), including the United States, China, Japan, India, and Germany, with a focus on countries where Korea's health products are exported a lot.

 

the survey was conducted on the subject.

 

As a result of the survey, awareness of Korea as a manufacturer of health products was 75.1%, up 3.5%p from 2021 (71.6%).

 

Specifically, the awareness rate in the pharmaceutical sector was 68.6% (▲4.8%) and the medical device sector was 68.6% (▲3.9%), and awareness rose significantly in Japan, Australia, and France.

 

Among Korean bio-health products, the number of consumers who are aware of a specific product stood at 67.1%, a slight increase from 65.8% in 2021.

 

The proportion of people who are aware of specific medical device products in Korea was 63.8%, an increase of 4.2%p compared to 2021.

 

When using Korean bio-health products for the first time, about 8 out of 10 (82.2%) knew that they were Korean products and used them, a slight increase compared to 2021 (81.5%).

 

As a result of asking 507 respondents who later recognized that it was a Korean bio-health product, the degree of change in perception after brand recognition, the average score of 100 was 67.2 points.

 

Respondents who used it for the first time before (67.1 points) before the outbreak of COVID-19 (67.2 points) had a higher opinion that 'positive changes' had taken place, and South America (76.9 points), Southeast Asia (72.7 points), and medical devices (69.1 points) The average score of 100 users was high.

 

By country, in Thailand, India, and France, Korean brand awareness before using the product was relatively low, while in Brazil, Kazakhstan, and Vietnam, there was a high change in positive awareness among post-recognizers.

 

After using Korean biohealth products, the overall satisfaction rate was 75.3 points, a decrease of 0.3 points compared to 2021.

 

By factor, quality, and efficacy satisfaction was the highest at 75.8 points, and the positive evaluation for product diversity (75.0 points) increased compared to the previous year.

 

In the field of medical devices, it was found that satisfaction with the diversity of Korean medical devices increased.

 

As a result of asking about the intention to recommend Korean bio-health products regardless of experience, active recommendation (voluntarily recommended) was 61.4 points and passive recommendation (not voluntarily, but recommended if someone asks) was 62.8 points, indicating active and passive recommendation.

 

All intentions increased year-on-year.

 

As for the reason for recommendation, the opinion that the efficacy of the product was ranked first (87.7%).

 

The willingness to recommend Korean bio-health products by 265 foreign experts was high at 60.1%, and cosmetics experts showed a willingness to recommend 83.3%, and the entire bio-health product industry showed a high willingness to recommend.

 

General consumers' overseas awareness of Korea's first medical service was 61.3%, and awareness was high in countries with many foreign patients visiting Korea, such as Vietnam, China, and Mongolia.

 

In addition, after Corona 19, the national brand and power awareness of Korean medical services has been strengthened, and it was high in countries such as Vietnam, Indonesia, UAE, and Saudi Arabia.

 

As a result of analyzing perceptions between Korean bio-health products and medical services, Vietnam, China, Thailand, and Indonesia all showed high awareness of manufacturing and medical services, while Kazakhstan, UAE, and Russia had higher awareness of Korean medical services than manufacturing.

 

investigated.

 

As a result of a correlation analysis between foreign patient attraction performance and medical service awareness by country, Korean medical services in China (1st place, 83.3%), Mongolia (5th place, 80.8%), and Vietnam (7th place, 91.7%) ranked high in foreign patient attraction.

 

Awareness of the service was very high.

 

In the Middle East, the UAE (10th, 74.2%) and Saudi Arabia (14th, 71.7%) showed a high level of awareness of Korean medical services compared to the performance of attracting foreign patients.

 

Han Dong-woo, head of the Health Industry Innovation Planning Division at the Promotion Agency, said, "This survey is significant in that it has been expanded not only to Korea's bio products, but also to the medical service sector, such as attracting foreign patients." Director Han said, "It is possible to objectively grasp overseas consumers' perceptions of our products and services in major bio health-related exporting countries and to analyze the differences and causes of awareness between our bio health products and medical services in the same country.

 

It is expected that our bio health industry will be highly utilized in establishing strategies for overseas expansion tailored to each foreign country."